<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.3.340">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>Type 2 diabetes in migrants: a register-based analysis - 6&nbsp; Discussion of results</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
/* CSS for citations */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging-indent div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<link href="./7-conclusions.html" rel="next">
<link href="./5-discussion-methods.html" rel="prev">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "sidebar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "start",
  "type": "textbox",
  "limit": 20,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit"
  }
}</script>

  <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
  <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml-full.js" type="text/javascript"></script>

</head>

<body class="nav-sidebar floating">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
  <nav class="quarto-secondary-nav">
    <div class="container-fluid d-flex">
      <button type="button" class="quarto-btn-toggle btn" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar,#quarto-sidebar-glass" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
        <i class="bi bi-layout-text-sidebar-reverse"></i>
      </button>
      <nav class="quarto-page-breadcrumbs" aria-label="breadcrumb"><ol class="breadcrumb"><li class="breadcrumb-item"><a href="./6-discussion-results.html"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">Discussion of results</span></a></li></ol></nav>
      <a class="flex-grow-1" role="button" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar,#quarto-sidebar-glass" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">      
      </a>
      <button type="button" class="btn quarto-search-button" aria-label="Search" onclick="window.quartoOpenSearch();">
        <i class="bi bi-search"></i>
      </button>
    </div>
  </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article">
<!-- sidebar -->
  <nav id="quarto-sidebar" class="sidebar collapse collapse-horizontal sidebar-navigation floating overflow-auto">
    <div class="pt-lg-2 mt-2 text-left sidebar-header">
    <div class="sidebar-title mb-0 py-0">
      <a href="./">Type 2 diabetes in migrants: a register-based analysis</a> 
    </div>
      </div>
        <div class="mt-2 flex-shrink-0 align-items-center">
        <div class="sidebar-search">
        <div id="quarto-search" class="" title="Search"></div>
        </div>
        </div>
    <div class="sidebar-menu-container"> 
    <ul class="list-unstyled mt-1">
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./index.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Cover Page</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./0-disclosure.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Notes and disclosures</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./0-preface.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Preface</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./0-papers.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Papers in the dissertation</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./0-abbreviations.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Abbreviations</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./1-introduction.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">Introduction</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./2-aims.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Aims</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./3-methods.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Material and methods</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./4-results.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Results in summary</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./5-discussion-methods.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Discussion of methods</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./6-discussion-results.html" class="sidebar-item-text sidebar-link active">
 <span class="menu-text"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">Discussion of results</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./7-conclusions.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Conclusions</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./8-perspectives.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">8</span>&nbsp; <span class="chapter-title">Perspectives and future research</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./references.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">References</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./summary-english.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">English summary</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./summary-danish.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Dansk resumé</span></a>
  </div>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="true">
 <span class="menu-text">Appendices</span></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="true" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-1" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./app1-supplementary.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">A</span>&nbsp; <span class="chapter-title">Supplementary validation analyses</span></span></a>
  </div>
</li>
      </ul>
  </li>
    </ul>
    </div>
</nav>
<div id="quarto-sidebar-glass" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar,#quarto-sidebar-glass"></div>
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">Table of contents</h2>
   
  <ul>
  <li><a href="#key-main-findings" id="toc-key-main-findings" class="nav-link active" data-scroll-target="#key-main-findings"><span class="header-section-number">6.1</span> Key main findings</a></li>
  <li><a href="#study-i" id="toc-study-i" class="nav-link" data-scroll-target="#study-i"><span class="header-section-number">6.2</span> Study I</a></li>
  <li><a href="#study-ii" id="toc-study-ii" class="nav-link" data-scroll-target="#study-ii"><span class="header-section-number">6.3</span> Study II</a></li>
  <li><a href="#study-iii" id="toc-study-iii" class="nav-link" data-scroll-target="#study-iii"><span class="header-section-number">6.4</span> Study III</a></li>
  <li><a href="#clinical-implications" id="toc-clinical-implications" class="nav-link" data-scroll-target="#clinical-implications"><span class="header-section-number">6.5</span> Clinical implications</a></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title"><span id="sec-discussion-results" class="quarto-section-identifier"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">Discussion of results</span></span></h1>
</div>



<div class="quarto-title-meta">

    
  
    
  </div>
  

</header>

<section id="key-main-findings" class="level2" data-number="6.1">
<h2 data-number="6.1" class="anchored" data-anchor-id="key-main-findings"><span class="header-section-number">6.1</span> Key main findings</h2>
<p>This dissertation identified several important findings in the three studies. First, study I determined whether register-based classifiers can identify valid populations of T1D and T2D in a general Danish population. Second, disparities in T2D care between migrants and native Danes were investigated in two cross-sectional studies. Study II analysed T2D prevalence and disparity in care quality as outlined in guideline recommendations for monitoring, biomarker levels and pharmacological treatment, while study III explored disparities in GLD treatment in terms of combination therapy and types of GLD used.</p>
<p>In this chapter, the main findings of each study are discussed separately and compared to existing literature before clinical implications of the results of studies II and III are discussed. Risk factors in T2D care beyond migrant origin are of great importance in a broader scope of equity in T2D care provision. However, they are not the focus of this dissertation and are only briefly discussed as they relate to migrants.</p>
</section>
<section id="study-i" class="level2" data-number="6.2">
<h2 data-number="6.2" class="anchored" data-anchor-id="study-i"><span class="header-section-number">6.2</span> Study I</h2>
<p>This study validated two predefined algorithms (the OSDC and the RSCD), which classified diabetes type in Danish register data against self-reported diabetes type in a Danish survey population. Overall, both classifiers performed excellent in terms of PPV in both T1D and T2D as well as sensitivity in T2D classification (all estimates 0.875 and above), and they had near-perfect accuracy in terms of specificity and NPV in both T1D and T2D (all estimates 0.989 and above). Both classifiers were unable to accurately classify diabetes type in individuals with T1D onset after age 40 years and T2D onset before age 40 years.</p>
<p>Sensitivity and NPV were higher in the OSDC than in the RSCD for both diabetes types. In T1D classification, these differences are attributable to differences in the algorithms, as both algorithms relied on the same data sources for identifying T1D (GLD use and type-specific diabetes diagnoses).<span class="citation" data-cites="ruks1doc"><sup><a href="references.html#ref-ruks1doc" role="doc-biblioref">1</a></sup></span> In T2D, this difference may be explained by the use of HbA1c data in the OSDC, which enables inclusion of diabetes cases at the time of diagnosis rather than requiring subsequent initiation of GLD treatment or hospitalisation. Specificity and PPV in T2D classification were higher in the RSCD than in the OSCD. This could possibly be explained by inclusion of milder cases in the latter, as this population may be less likely to correctly report having diabetes (e.g.&nbsp;if an individual had never purchased GLD or been hospitalised for the disease). Notably, the demographic characteristics of the register-classified diabetes populations differed, particularly in T1D, where the higher sensitivity of the OSDC in women (0.846 vs.&nbsp;0.725 in supplementary analyses) resulted in a higher prevalence of women in the OSDC population compared to the RSCD population. This is in line with a previous study comparing the Danish National Diabetes Register (which did not use HbA1c) against a local database containing HbA1c as an alternative inclusion criterion, which found higher prevalences of diabetes in the HbA1c-augmented definition, especially among women.<span class="citation" data-cites="RN165"><sup><a href="references.html#ref-RN165" role="doc-biblioref">2</a></sup></span></p>
<p>To the best of my knowledge, this study was the first to validate the performance of a type-specific diabetes classifier in a general population of individuals with and without diabetes. Other studies have validated type-specific diabetes classifier performance in populations consisting only of individuals with diabetes, which fails to test the ability of the algorithm to distinguish individuals with diabetes from those without. This overestimates the accuracy of the algorithm compared to its performance in a general population. In addition, both algorithms were pre-specified, as opposed to the data-driven, exploratory approaches used in other validation studies to design algorithms optimized for a particular dataset, which holds a risk of overfitting the algorithm to the dataset and reducing the external validity of findings.<span class="citation" data-cites="RN174 RN179 RN177"><sup><a href="references.html#ref-RN174" role="doc-biblioref">3</a>–<a href="references.html#ref-RN177" role="doc-biblioref">5</a></sup></span> Despite these differences, the performance of both our classifiers was superior to the performance of T1D classification reported in studies in the United States and Hong Kong,<span class="citation" data-cites="RN174 RN178"><sup><a href="references.html#ref-RN174" role="doc-biblioref">3</a>,<a href="references.html#ref-RN178" role="doc-biblioref">6</a></sup></span> and comparable to that reported in the United Kingdom,<span class="citation" data-cites="RN172"><sup><a href="references.html#ref-RN172" role="doc-biblioref">7</a></sup></span> but inferior to that reported in a study in Canada.<span class="citation" data-cites="RN177"><sup><a href="references.html#ref-RN177" role="doc-biblioref">5</a></sup></span></p>
<p>The poor performance of the register-based classifiers in subgroups with diabetes onset at atypical age is likely to reflect clinical uncertainty in these cases. This may result in inaccurate type-specific diabetes diagnoses and uncharacteristic GLD purchase patterns,<span class="citation" data-cites="RN173"><sup><a href="references.html#ref-RN173" role="doc-biblioref">8</a></sup></span> which may lead the algorithms to misclassify these individuals. Sensitivity in T1D classification has previously been reported to be highly dependent on age at onset,<span class="citation" data-cites="RN179"><sup><a href="references.html#ref-RN179" role="doc-biblioref">4</a></sup></span> and our findings indicate that this issue also extends to PPV and to T2D classification.</p>
</section>
<section id="study-ii" class="level2" data-number="6.3">
<h2 data-number="6.3" class="anchored" data-anchor-id="study-ii"><span class="header-section-number">6.3</span> Study II</h2>
<p>This study analysed the prevalence of T2D and disparities between migrant groups and native Danes across eleven indicators of guideline recommendations on monitoring, biomarker levels and pharmacological treatment.</p>
<p>The prevalence of T2D was found to be higher in migrants compared to native Danes, especially in migrants from Sri Lanka and Pakistan, who were four to five times more likely to have T2D compared to native Danes. While similar findings have previously been reported in Denmark<span class="citation" data-cites="andersen2016 Kristensen2007"><sup><a href="references.html#ref-andersen2016" role="doc-biblioref">9</a>,<a href="references.html#ref-Kristensen2007" role="doc-biblioref">10</a></sup></span> and across Europe,<span class="citation" data-cites="meeks2016"><sup><a href="references.html#ref-meeks2016" role="doc-biblioref">11</a></sup></span> our study shows that this risk persists after adjusting for differences in socioeconomic position.</p>
<p>Failure to fulfil guideline recommendations and targets for T2D care was common. The proportion of native Danes unable to fulfil recommendations was below 10% in only two indicators (HbA1c-monitoring and GLD-treatment) and above 25% in eight (all remaining indicators excluding LDL-C monitoring). Non-fulfilment of guideline recommendations was more common in migrants, particularly in terms of monitoring and controlling HbA1c and LDL-C levels. In most of these indicators, we observed increased crude risks at a significance level of <span class="math inline">\(\alpha = 0.05\)</span> in most migrant groups, whereas no clear overall pattern was observed across migrant groups in the indicators of pharmacological treatment.</p>
<p>The disparity between migrants and native Danes was largest in the indicators of glycaemic control and screening for diabetic foot disease (crude risk was increased by more than one-third in most migrant groups). Migrants from Somalia stood out across all aspects of T2D care. The group had increased crude risk in all eleven indicators, and the highest risk of all migrants in nine. In addition, the largest single disparity was observed in migrants from Somalia, who had almost twice the crude risk of native Danes in the indicator of lipid control.</p>
<p>Our findings of lower likelihood of T2D monitoring in most migrant groups contrast the findings in prior studies, where migrants received similar or more monitoring compared to native Danes,<span class="citation" data-cites="Kristensen2007"><sup><a href="references.html#ref-Kristensen2007" role="doc-biblioref">10</a></sup></span> Norwegians<span class="citation" data-cites="Tran2010"><sup><a href="references.html#ref-Tran2010" role="doc-biblioref">12</a></sup></span> and Swedes.<span class="citation" data-cites="Rawshani2015"><sup><a href="references.html#ref-Rawshani2015" role="doc-biblioref">13</a></sup></span> Still, it is in line with recent findings of less timely monitoring in ethnic minority groups in England.<span class="citation" data-cites="Whyte2019"><sup><a href="references.html#ref-Whyte2019" role="doc-biblioref">14</a></sup></span> The proportion of the T2D population without timely monitoring varied substantially between each type of monitoring, but socioeconomic factors such as household income and region of residence were risk factors in all types of monitoring. Screening for diabetic foot disease is the only service that is not fully covered by the public health insurance in Denmark (requiring the patient to pay a fee), which may explain why this indicator had the highest proportion of individuals without timely monitoring. In addition, the large disparity between migrants and native Danes in this indicator, which persisted after adjusting for socioeconomic variables, suggests that economic barriers may disproportionately limit the access to care in migrant groups.</p>
<p>In line with previous studies, most migrant groups were less likely than native Danes to achieve glycaemic control.<span class="citation" data-cites="Tran2010 Negandhi2013 Whyte2019"><sup><a href="references.html#ref-Rawshani2015" role="doc-biblioref">13</a></sup></span> The magnitude of the risk was similar to what has previously been reported, although it may seem lower compared to estimates reported as ORs in other studies, since ORs may lead to exaggerated risk estimates if interpreted as RR when the outcome is common.<span class="citation" data-cites="holcomb2001"><sup><a href="references.html#ref-holcomb2001" role="doc-biblioref">16</a></sup></span> For example, a study in Scotland reported a crude OR of dysglycaemia of 2.2 in the Pakistani group and a dysglycaemia-prevalence of roughly 50% in the reference group;<span class="citation" data-cites="Negandhi2013"><sup><a href="references.html#ref-Negandhi2013" role="doc-biblioref">15</a></sup></span> this corresponds to an RR of 1.4,<span class="citation" data-cites="Grant2014"><sup><a href="references.html#ref-Grant2014" role="doc-biblioref">17</a></sup></span> which is similar to our estimate.</p>
<p>To the best of my knowledge, increased LDL-C levels among migrants have not previously been reported,<span class="citation" data-cites="Eastwood2021"><sup><a href="references.html#ref-Eastwood2021" role="doc-biblioref">18</a></sup></span> although a small US study noted a minor trend towards higher lipid levels in migrants from Somalia.<span class="citation" data-cites="Wieland2012"><sup><a href="references.html#ref-Wieland2012" role="doc-biblioref">19</a></sup></span> Three studies have examined obesity in migrants from Somalia and found high prevalences of obesity and increased waist-to-hip ratio in women, but not in men.<span class="citation" data-cites="Gele2013 Skogberg2018 Ahmed2018"><sup><a href="references.html#ref-Gele2013" role="doc-biblioref">20</a>–<a href="references.html#ref-Ahmed2018" role="doc-biblioref">22</a></sup></span> If this pattern between sexes extends to migrants from Somalia in Denmark, it seems unlikely that anthropometric factors alone can explain the high levels of LDL-C in this population, as the risk remained unchanged in supplementary analyses stratified by sex (not included in this dissertation).</p>
<p>Most studies of pharmacological treatment in T2D have analysed the whole population (rather than analysing groups with a clinical indication for treatment) and have evaluated incident medication use in cohorts of newly diagnosed, making direct comparisons to our findings difficult. The finding of lower or similar risk of GLD non-use in most migrant groups is in line with previous studies comparing migrants to native populations.<span class="citation" data-cites="Tran2010 Rawshani2015"><sup><a href="references.html#ref-Tran2010" role="doc-biblioref">12</a>,<a href="references.html#ref-Rawshani2015" role="doc-biblioref">13</a></sup></span> However, the lower risk of LLD non-use in most migrant groups contrasts findings from prior studies.<span class="citation" data-cites="RamirezSanchez2013 Tran2010 Eastwood2021"><sup><a href="references.html#ref-Tran2010" role="doc-biblioref">12</a>,<a href="references.html#ref-Eastwood2021" role="doc-biblioref">18</a>,<a href="references.html#ref-RamirezSanchez2013" role="doc-biblioref">23</a></sup></span> The increased risk of dysglycaemia in the Somalia group coincided with an increased risk of not receiving GLD. This pattern was also observed for dyslipidaemia and LLD non-use in the Somalia and Europe groups, indicating a particular need to the increase uptake of pharmacological treatment in these groups. Similar to a study from Italy, we found a higher risk of not receiving ACEI/ARB treatment in most migrant groups. In contrast, the risk of not receiving APT was similar in most groups in our study.<span class="citation" data-cites="Marzona2018"><sup><a href="references.html#ref-Marzona2018" role="doc-biblioref">24</a></sup></span> As the indications for treatment with ACEI/ARB and APT were identical in our study, one might expect similar risk patterns in these outcomes. Yet, this was not the case, which might be due to unmeasured differences between the groups in terms of indications, counter-indications, awareness of and attitude to these drugs.</p>
<p>Some of the disparities between migrants and native Danes could be attributed to a higher prevalence of risk factors of poor T2D care in migrants; specifically young age, low household income and residence in the Capital Region of Denmark.</p>
</section>
<section id="study-iii" class="level2" data-number="6.4">
<h2 data-number="6.4" class="anchored" data-anchor-id="study-iii"><span class="header-section-number">6.4</span> Study III</h2>
<p>This study explored disparities in GLD treatment in terms of combination therapy and types of GLD used, adding to the analysis of the indicator of GLD treatment performed in study II. The analysis of GLD in study II found no overall pattern of disparity across migrant groups, but it did not capture nuances in the treatment provided, because the analysis was a simple evaluation of any GLD treatment being present or not. In this study, most migrant groups were found to be less likely to receive combination GLD therapy than native Danes. We also found that, compared to native Danes, most migrant groups were more likely to receive oral GLD types (metformin, sulfonylureas, DPP4i, and SGLT2i) and less likely to receive injection-based GLD types (insulins and GLP1RA). Disparity was largest in GLP1RA use, where the RR ranged from 0.30 to 0.60 in most migrant groups.</p>
<p>As in study II, migrants from Somalia stood out; they had the lowest likelihood of receiving combination therapy and GLP1RA of all groups.</p>
<p>To the best of my knowledge, combination therapy usage has not previously been studied in migrants. Still, disparities between racial groups have been examined, and these proxies of ethnicity provide a basis for comparisons. With the notable exception of migrants in the four smallest migrant groups (Pakistan, Sri Lanka, Somalia and Vietnam), the migrants in our study received combination therapy on a level close to native Danes after adjustments (RRs around 0.95 to 1.05). Since combination therapy is not a hard clinical endpoint, we argue that the modest disparities observed in the largest groups of migrants (covering more than three-quarters of the total migrant T2D population) were insignificant from a clinical perspective. At a glance, this may contrast another UK study reporting a high odds ratio of experiencing inertia in initiation of combination therapy in non-white groups compared to Whites (e.g.&nbsp;odds ratio in Blacks: 1.43) and reporting their findings as persuasive evidence of disparities.<span class="citation" data-cites="RN226"><sup><a href="references.html#ref-RN226" role="doc-biblioref">25</a></sup></span> However, the high prevalence of inertia in the reference group (67.1%) of the study exaggerates this risk estimate if interpreted as RR, and the corresponding RR (around 1.11 in Blacks)<span class="citation" data-cites="Grant2014"><sup><a href="references.html#ref-Grant2014" role="doc-biblioref">17</a></sup></span> is more in line with our findings.</p>
<p>The higher prevalence of metformin, sulfonylurea and DPP4i in migrant groups is in line with previous reports in non-white minorities.<span class="citation" data-cites="Whyte2019 RN225"><sup><a href="references.html#ref-Whyte2019" role="doc-biblioref">14</a>,<a href="references.html#ref-RN225" role="doc-biblioref">26</a></sup></span> The particularly high prevalence of sulfonylureas in migrants from Vietnam may reflect care being influenced by practice in the origin country, as sulfonylureas are used in roughly three quarters of all T2D patients in Vietnam.<span class="citation" data-cites="RN238"><sup><a href="references.html#ref-RN238" role="doc-biblioref">27</a></sup></span> In contrast, the higher prevalence of SGLT2 found in our study contradicts previous studies on racial minorities.<span class="citation" data-cites="RN225 RN222 RN219"><sup><a href="references.html#ref-RN225" role="doc-biblioref">26</a>,<a href="references.html#ref-RN222" role="doc-biblioref">28</a>,<a href="references.html#ref-RN219" role="doc-biblioref">29</a></sup></span> The very low prevalence of GLP1RA use in migrants compared to the native population has not previously been reported, but is in line with previous reports of disparities in non-white minorities.<span class="citation" data-cites="Whyte2019 RN225 RN222"><sup><a href="references.html#ref-Whyte2019" role="doc-biblioref">14</a>,<a href="references.html#ref-RN225" role="doc-biblioref">26</a>,<a href="references.html#ref-RN222" role="doc-biblioref">28</a></sup></span> Similarly, the low prevalence of insulin treatment in migrants with T2D is consistent with an Italian study<span class="citation" data-cites="Marchesini2014"><sup><a href="references.html#ref-Marchesini2014" role="doc-biblioref">30</a></sup></span> and studies on non-white minorities elsewhere.<span class="citation" data-cites="Whyte2019 RN236"><sup><a href="references.html#ref-Whyte2019" role="doc-biblioref">14</a>,<a href="references.html#ref-RN236" role="doc-biblioref">31</a></sup></span></p>
<p>The main analyses were limited to GLD use in 2019, as we only had access to data on co-variables in the time before 2019. GLD treatment practice changed considerably in the subsequent years (even before the broadening of GLP1RA/SGLT2i-recommendations in 2022), and our findings may not persist in the new clinical context. However, supplementary analyses of GLD use in 2021 found that, despite substantial changes to GLD use compared to 2019, including &gt;50% increases in GLP1RA and SGLT2i user-prevalences, disparities between migrants and native Danes remained unchanged. This may indicate that our findings are robust rather than limited to a clinical setting of narrow indication or low prevalence of use of these drugs.</p>
</section>
<section id="clinical-implications" class="level2" data-number="6.5">
<h2 data-number="6.5" class="anchored" data-anchor-id="clinical-implications"><span class="header-section-number">6.5</span> Clinical implications</h2>
<p>In study II, the evaluation of quality of care using binary process and outcome indicators does not capture qualitative differences in the provided care, nor does it account for valid patient-specific reasons for not providing care or achieving biomarker control. In some individuals, failure to achieve biomarker control may be unrelated to the quality of provided care (e.g.&nbsp;due to genetic factors), and a lack of monitoring may not affect risk factors and the risk of adverse outcomes. In contrast, there is less leeway for the timely provision of pharmacological treatment to patients with a guideline indication for treatment. Drug side-effects or contra-indications may be valid clinical reasons for a patient to not receive a particular drug. However, this is likely to only explain a very small fraction of non-users, as it is unlikely that these reasons prohibit all treatment options offered by guidelines (e.g.&nbsp;all types of GLD or LLD). Thus, relative to monitoring and biomarker levels, the clinical implications of disparities in pharmacological treatment are clearer, and they require further discussion below.</p>
<p>Barriers to pharmacological treatment may originate from the healthcare system, the clinician, and the patient. Therefore, efforts to increase the use should target these.</p>
<p>Healthcare policies affecting patient-incurred costs are major determinants of pharmacological treatment accessibility.<span class="citation" data-cites="RN231 RN232"><sup><a href="references.html#ref-RN231" role="doc-biblioref">32</a>,<a href="references.html#ref-RN232" role="doc-biblioref">33</a></sup></span> In the Danish universal healthcare system, the annual drug expenditures are partially covered from €132 and fully covered from €553 (2019 limits). While patients with higher medication expenses will incur similar costs, regardless of the number or types of GLD used, patients treated with fewer, less expensive drugs will receive only limited coverage, and they may perceive costs as a barrier to using the newer, more expensive GLD types. In study III there were indications of financial barriers to using the more expensive GLD regimens, as lower household income was associated with less use of triple combination therapy, SGLT2i and GLP1RA (see supplementary material). This could indicate that broader coverage of GLD expenditures may serve to increase the use of combination therapy, SGLT2i and GLP1RA in the poorest patient groups, in which migrants constitute a disproportionately large share.</p>
<p>Clinicians may be reluctant to prescribe insulin in migrants if a language barrier is present, given the complex nature of administrations and the risk of hypoglycaemia. However, the use of GLP1RA does not carry these risks and should not take up more resources of the prescriber (e.g.&nbsp;physician or staff consultation time) over oral GLD, even if language barriers are present. Increasing GP awareness of disparities in pharmacological treatment of migrants with T2D (e.g.&nbsp;by increasing focus on migrants in clinical guidelines) may reduce the risk of suboptimal pharmacological treatment in these groups.</p>
<p>Patient preference of oral administration over injection-based drugs is also likely to influence prescribing. Migrant origin may influence this preference, which could explain the divergent findings between oral and injection drugs, particularly between GLP1RA and SGLT2i. Other studies have reported several reasons for insulin-aversion among migrants, including fears of weight gain, loss of independence, risk of hypoglycemia and death.<span class="citation" data-cites="RN233 RN234 RN239"><sup><a href="references.html#ref-RN233" role="doc-biblioref">34</a>–<a href="references.html#ref-RN239" role="doc-biblioref">36</a></sup></span> Similar fears may be present for GLP1RA use in migrants due to the administration similarities to insulin injections, and patient education may be able to address these.</p>
<p>The massive disparities faced by migrants from Somalia in all areas of care studied in this PhD project hold particular implications for clinicians (and perhaps also for health planners and local communities). Overall, they indicate that clinicians treating patients in this group should consider close attention to care quality in this group, particularly in relation to pharmacological treatment with GLDs and LLDs. Specifically, LLDs are available in relatively inexpensive oral form, and expenditures and patient preference seem less likely to be major barriers to use of these drugs. Therefore, increasing awareness among GPs to the high lipid levels and need for LLD treatment in patients from Somalia with T2D may be a potential approach to increase treatment quality and reduce complication risk in this group.</p>


<div id="refs" class="references csl-bib-body" role="list" style="display: none">
<div id="ref-ruks1doc" class="csl-entry" role="listitem">
<div class="csl-left-margin">1. </div><div class="csl-right-inline">Sundhedsdatastyrelsen [English: Danish Health Data Authority]. <span class="nocase">Algoritmer for udvalgte kroniske sygdomme og svære psykiske lidelser [English: Algorithms for selected chronic diseases and serious mental illnesses]</span> [Internet]. {2016, last accessed 7 Feb 2023};Available from: <a href="https://www.esundhed.dk/-/media/Files/Dokumentation/Register-for-Udvalgte-Kroniske-Sygdomme-og-Svaere-Psykiske-Lidelser/29_Algoritmer_for_RUKS.ashx">https://www.esundhed.dk/-/media/Files/Dokumentation/Register-for-Udvalgte-Kroniske-Sygdomme-og-Svaere-Psykiske-Lidelser/29_Algoritmer_for_RUKS.ashx</a></div>
</div>
<div id="ref-RN165" class="csl-entry" role="listitem">
<div class="csl-left-margin">2. </div><div class="csl-right-inline">Nielsen AA, Christensen H, Lund ED, Christensen C, Brandslund I, Green A. Diabetes mortality differs between registers due to various disease definitions. Dan Med J 2014;61(5):A4840. </div>
</div>
<div id="ref-RN174" class="csl-entry" role="listitem">
<div class="csl-left-margin">3. </div><div class="csl-right-inline">Klompas M, Eggleston E, McVetta J, Lazarus R, Li L, Platt R. <a href="https://doi.org/10.2337/dc12-0964">Automated detection and classification of type 1 versus type 2 diabetes using electronic health record data</a>. Diabetes Care 2013;36(4):914–21. </div>
</div>
<div id="ref-RN179" class="csl-entry" role="listitem">
<div class="csl-left-margin">4. </div><div class="csl-right-inline">Ke C, Stukel TA, Luk A, et al. Development and validation of algorithms to classify type 1 and 2 diabetes according to age at diagnosis using electronic health records. BMC Medical Research Methodology [Internet] 2020;20(1):35. Available from: <a href="https://doi.org/10.1186/s12874-020-00921-3">https://doi.org/10.1186/s12874-020-00921-3</a></div>
</div>
<div id="ref-RN177" class="csl-entry" role="listitem">
<div class="csl-left-margin">5. </div><div class="csl-right-inline">Weisman A, Tu K, Young J, et al. <a href="https://doi.org/10.1136/bmjdrc-2020-001224">Validation of a type 1 diabetes algorithm using electronic medical records and administrative healthcare data to study the population incidence and prevalence of type 1 diabetes in ontario, canada</a>. BMJ Open Diabetes Res Care 2020;8(1). </div>
</div>
<div id="ref-RN178" class="csl-entry" role="listitem">
<div class="csl-left-margin">6. </div><div class="csl-right-inline">Lynam A, McDonald T, Hill A, et al. <a href="https://doi.org/10.1136/bmjopen-2019-031586">Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years</a>. BMJ Open 2019;9(9):e031586. </div>
</div>
<div id="ref-RN172" class="csl-entry" role="listitem">
<div class="csl-left-margin">7. </div><div class="csl-right-inline">Thomas NJ, McGovern A, Young KG, et al. Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: Assessing the accuracy of published approaches. J Clin Epidemiol [Internet] 2022;Available from: <a href="https://www.ncbi.nlm.nih.gov/pubmed/36368478">https://www.ncbi.nlm.nih.gov/pubmed/36368478</a></div>
</div>
<div id="ref-RN173" class="csl-entry" role="listitem">
<div class="csl-left-margin">8. </div><div class="csl-right-inline">Thomas NJ, Lynam AL, Hill AV, et al. <a href="https://doi.org/10.1007/s00125-019-4863-8">Type 1 diabetes defined by severe insulin deficiency occurs after 30&nbsp;years of age and is commonly treated as type 2 diabetes</a>. Diabetologia 2019;62(7):1167–72. </div>
</div>
<div id="ref-andersen2016" class="csl-entry" role="listitem">
<div class="csl-left-margin">9. </div><div class="csl-right-inline">Andersen GS, Kamper-Jørgensen Z, Carstensen B, Norredam M, Bygbjerg IC, Jørgensen ME. <a href="https://doi.org/10.1016/j.diabres.2016.09.020"><span class="nocase">Diabetes among migrants in Denmark: Incidence, mortality, and prevalence based on a longitudinal register study of the entire Danish population</span></a>. Diabetes Res Clin Pract 2016;Dec:122:9–16. </div>
</div>
<div id="ref-Kristensen2007" class="csl-entry" role="listitem">
<div class="csl-left-margin">10. </div><div class="csl-right-inline">Kristensen J, Bak J, Wittrup I, Lauritzen T. <a href="https://doi.org/10.1016/j.pcd.2007.07.007"><span class="nocase">Diabetes prevalence and quality of diabetes care among Lebanese or Turkish immigrants compared to a native Danish population</span></a>. Prim Care Diabetes 2007;Sep:1(3):159–65. </div>
</div>
<div id="ref-meeks2016" class="csl-entry" role="listitem">
<div class="csl-left-margin">11. </div><div class="csl-right-inline">Meeks KA, Freitas-Da-Silva D, Adeyemo A, et al. <a href="https://doi.org/10.1007/s11739-015-1302-9"><span class="nocase">Disparities in type 2 diabetes prevalence among ethnic minority groups resident in Europe: a systematic review and meta-analysis</span></a>. Intern Emerg Med 2016;Apr; 11(3):327-40. </div>
</div>
<div id="ref-Tran2010" class="csl-entry" role="listitem">
<div class="csl-left-margin">12. </div><div class="csl-right-inline">Tran AT, Diep LM, Cooper JG, et al. <a href="https://doi.org/10.1186/1472-6963-10-145"><span class="nocase">Quality of care for patients with type 2 diabetes in general practice according to patients’ ethnic background: a cross-sectional study from Oslo, Norway</span></a>. BMC Health Serv Res 2010;10, 145. </div>
</div>
<div id="ref-Rawshani2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">13. </div><div class="csl-right-inline">Rawshani A, Svensson A, Rosengren A, Zethelius B, Eliasson B, Gudbjörnsdottir S. <a href="https://doi.org/10.1136/bmjopen-2015-007599"><span class="nocase">Impact of ethnicity on progress of glycaemic control in 131935 newly diagnosed patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register</span></a>. BMJ Open 2015;5;e007599. </div>
</div>
<div id="ref-Whyte2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">14. </div><div class="csl-right-inline">Whyte MB, Hinton W, McGovern A, et al. <a href="https://doi.org/10.1371/journal.pmed.1002942"><span class="nocase">Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis</span></a>. PLoS Med 2019;Oct 7; 16(10):e1002942. </div>
</div>
<div id="ref-Negandhi2013" class="csl-entry" role="listitem">
<div class="csl-left-margin">15. </div><div class="csl-right-inline">Negandhi PH, Ghouri N, Colhoun HM, et al. <a href="https://doi.org/10.1371/journal.pone.0083292"><span class="nocase">Ethnic Differences in Glycaemic Control in People with Type 2 Diabetes Mellitus Living in Scotland</span></a>. PLoS ONE 2013;8. </div>
</div>
<div id="ref-holcomb2001" class="csl-entry" role="listitem">
<div class="csl-left-margin">16. </div><div class="csl-right-inline">Holcomb WL, Chaiworapongsa T, Luke DA, Burgdorf KD. <a href="https://doi.org/10.1016/S0029-7844(01)01488-0"><span class="nocase">An odd measure of risk: use and misuse of the odds ratio</span></a>. Obstetrics &amp; Gynecology 2001;98(4):685–8. </div>
</div>
<div id="ref-Grant2014" class="csl-entry" role="listitem">
<div class="csl-left-margin">17. </div><div class="csl-right-inline">Grant RL. <a href="https://doi.org/10.1136/bmj.f7450"><span class="nocase">Converting an odds ratio to a range of plausible relative risks for better communication of research findings</span></a>. BMJ 2014;348. </div>
</div>
<div id="ref-Eastwood2021" class="csl-entry" role="listitem">
<div class="csl-left-margin">18. </div><div class="csl-right-inline">Eastwood SV, Mathur R, Sattar N, Smeeth L, Bhaskaran K, Chaturvedi N. <a href="https://doi.org/10.1371/journal.pmed.1003672"><span class="nocase">Ethnic differences in guideline-indicated statin initiation for people with type 2 diabetes in UK primary care, 2006-2019: A cohort study</span></a>. PLoS Med 2021;18. </div>
</div>
<div id="ref-Wieland2012" class="csl-entry" role="listitem">
<div class="csl-left-margin">19. </div><div class="csl-right-inline">Wieland ML, Morrison TB, Cha SS, Rahman AS, Chaudhry R. <a href="https://doi.org/10.1007/s10900-011-9499-7"><span class="nocase">Diabetes Care Among Somali Immigrants and Refugees</span></a>. J Community Health 2012;37:680–4. </div>
</div>
<div id="ref-Gele2013" class="csl-entry" role="listitem">
<div class="csl-left-margin">20. </div><div class="csl-right-inline">Gele AA, Mbalilaki AJ. <a href="https://doi.org/10.1186/1756-0500-6-119"><span class="nocase">Overweight and obesity among African immigrants in Oslo</span></a>. BMC Res Notes 2013;6. </div>
</div>
<div id="ref-Skogberg2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">21. </div><div class="csl-right-inline">Skogberg N, Laatikainen T, Lundqvist A, Lilja E, H�rk�nen T, Koponen P. <a href="https://doi.org/10.1136/bmjopen-2017-019166"><span class="nocase">Which anthropometric measures best indicate type 2 diabetes among Russian, Somali and Kurdish migrants in Finland? A cross-sectional study</span></a>. BMJ Open 2018;8. </div>
</div>
<div id="ref-Ahmed2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">22. </div><div class="csl-right-inline">Ahmed S, Meyer HE, Kj�llesdal MK, Madar MA. <a href="https://doi.org/10.1155/2018/4539171"><span class="nocase">Prevalence and Predictors of Overweight and Obesity among Somalis in Norway and Somaliland: A Comparative Study</span></a>. Journal of Obesity 2018;</div>
</div>
<div id="ref-RamirezSanchez2013" class="csl-entry" role="listitem">
<div class="csl-left-margin">23. </div><div class="csl-right-inline">Ramirez-Sanchez DC, Krasnik A, Kildemoes HW. <a href="https://doi.org/10.1007/s00228-012-1306-6"><span class="nocase">Do immigrants from Turkey, Pakistan and Ex-Yugoslavia with newly diagnosed type 2 diabetes initiate recommended statin therapy to the same extent as Danish-born residents? A nationwide register study</span></a>. Eur J Clin Pharmacol 2013;69:87–95. </div>
</div>
<div id="ref-Marzona2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">24. </div><div class="csl-right-inline">Marzona I, Avanzini F, Tettamanti M, et al. <a href="https://doi.org/10.1007/s00592-018-1102-6"><span class="nocase">Prevalence and management of diabetes in immigrants resident in the Lombardy Region: the importance of ethnicity and duration of stay</span></a>. Acta Diabetol 2018;55:355–62. </div>
</div>
<div id="ref-RN226" class="csl-entry" role="listitem">
<div class="csl-left-margin">25. </div><div class="csl-right-inline">Mathur R, Farmer RE, Eastwood SV, Chaturvedi N, Douglas I, Smeeth L. <a href="https://doi.org/10.1371/journal.pmed.1003106">Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study</a>. PLoS Med 2020;17(5):e1003106. </div>
</div>
<div id="ref-RN225" class="csl-entry" role="listitem">
<div class="csl-left-margin">26. </div><div class="csl-right-inline">Elhussein A, Anderson A, Bancks MP, et al. <a href="https://doi.org/10.1016/j.lana.2021.100111">Racial/ethnic and socioeconomic disparities in the use of newer diabetes medications in the look AHEAD study</a>. Lancet Reg Health Am 2022;6. </div>
</div>
<div id="ref-RN238" class="csl-entry" role="listitem">
<div class="csl-left-margin">27. </div><div class="csl-right-inline">Lim L-L, Lau ESH, Cheung JTK, et al. Real-world usage of sulphonylureas in asian patients with type 2 diabetes using the joint asia diabetes evaluation (JADE) register. Diabetes, Obesity and Metabolism [Internet] 2023;25(1):208–21. Available from: <a href="https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.14865">https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.14865</a></div>
</div>
<div id="ref-RN222" class="csl-entry" role="listitem">
<div class="csl-left-margin">28. </div><div class="csl-right-inline">Lamprea-Montealegre JA, Madden E, Tummalapalli SL, et al. <a href="https://doi.org/10.1001/jama.2022.13885">Association of race and ethnicity with prescription of SGLT2 inhibitors and GLP1 receptor agonists among patients with type 2 diabetes in the veterans health administration system</a>. Jama 2022;328(9):861–71. </div>
</div>
<div id="ref-RN219" class="csl-entry" role="listitem">
<div class="csl-left-margin">29. </div><div class="csl-right-inline">Bidulka P, Mathur R, Lugo-Palacios DG, et al. Ethnic and socioeconomic disparities in initiation of second-line antidiabetic treatment for people with type 2 diabetes in england: A cross-sectional study. Diabetes, Obesity and Metabolism [Internet] 2023;25(1):282–92. Available from: <a href="https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.14874">https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.14874</a></div>
</div>
<div id="ref-Marchesini2014" class="csl-entry" role="listitem">
<div class="csl-left-margin">30. </div><div class="csl-right-inline">Marchesini G, Bernardi D, Miccoli R, et al. <a href="https://doi.org/10.1016/j.numecd.2013.09.012"><span class="nocase">Under-treatment of migrants with diabetes in a universalistic health care system: The ARNO Observatory</span></a>. Nutr Metab Cardiovasc Dis 2014;24. </div>
</div>
<div id="ref-RN236" class="csl-entry" role="listitem">
<div class="csl-left-margin">31. </div><div class="csl-right-inline">Li P, Zhang P, Guan D, et al. <a href="https://doi.org/10.1111/dom.14894">Changes in racial and ethnic disparities in glucose-lowering drug utilization and glycated haemoglobin A1c in US adults with diabetes: 2005-2018</a>. Diabetes Obes Metab 2023;25(2):516–25. </div>
</div>
<div id="ref-RN231" class="csl-entry" role="listitem">
<div class="csl-left-margin">32. </div><div class="csl-right-inline">Dor A, Encinosa W. How does cost-sharing affect drug purchases? Insurance regimes in the private market for prescription drugs. National Bureau of Economic Research Working Paper Series [Internet] 2004;No. 10738. Available from: <a href="http://www.nber.org/papers/w10738">http://www.nber.org/papers/w10738</a></div>
</div>
<div id="ref-RN232" class="csl-entry" role="listitem">
<div class="csl-left-margin">33. </div><div class="csl-right-inline">McManus P, Donnelly N, Henry D, Hall W, Primrose J, Lindner J. <a href="https://doi.org/10.1002/(sici)1099-1557(199611)5:6<385::Aid-pds246>3.0.Co;2-8">Prescription drug utilization following patient co-payment changes in australia</a>. Pharmacoepidemiol Drug Saf 1996;5(6):385–92. </div>
</div>
<div id="ref-RN233" class="csl-entry" role="listitem">
<div class="csl-left-margin">34. </div><div class="csl-right-inline">Khan H, Lasker SS, Chowdhury TA. <a href="https://doi.org/10.1111/j.1464-5491.2008.02538.x">Prevalence and reasons for insulin refusal in bangladeshi patients with poorly controlled type 2 diabetes in east london</a>. Diabet Med 2008;25(9):1108–11. </div>
</div>
<div id="ref-RN234" class="csl-entry" role="listitem">
<div class="csl-left-margin">35. </div><div class="csl-right-inline">Hu J, Amirehsani KA, Wallace DC, Letvak S. The meaning of insulin to hispanic immigrants with type 2 diabetes and their families. The Diabetes Educator [Internet] 2012;38(2):263–70. Available from: <a href="https://journals.sagepub.com/doi/abs/10.1177/0145721712437559">https://journals.sagepub.com/doi/abs/10.1177/0145721712437559</a></div>
</div>
<div id="ref-RN239" class="csl-entry" role="listitem">
<div class="csl-left-margin">36. </div><div class="csl-right-inline">Mull DS, Nguyen N, Mull JD. <a href="https://doi.org/10.1136/ewjm.175.5.307">Vietnamese diabetic patients and their physicians: What ethnography can teach us</a>. West J Med 2001;175(5):307–11. </div>
</div>
</div>
</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    text: function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
<nav class="page-navigation">
  <div class="nav-page nav-page-previous">
      <a href="./5-discussion-methods.html" class="pagination-link">
        <i class="bi bi-arrow-left-short"></i> <span class="nav-page-text"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Discussion of methods</span></span>
      </a>          
  </div>
  <div class="nav-page nav-page-next">
      <a href="./7-conclusions.html" class="pagination-link">
        <span class="nav-page-text"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Conclusions</span></span> <i class="bi bi-arrow-right-short"></i>
      </a>
  </div>
</nav>
</div> <!-- /content -->



</body></html>